𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Rituximab in Active Ulcerative Colitis

✍ Scribed by Elisabeth Calderón–Gómez; Julián Panés

Book ID
119762065
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
161 KB
Volume
142
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rifaximin for active ulcerative colitis
Rifaximin for active ulcerative colitis
✍ Mario Guslandi; Maria Chiara Petrone; Pier Alberto Testoni 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB
Exacerbation of ulcerative colitis after
Exacerbation of ulcerative colitis after rituximab salvage therapy
✍ Martin Goetz; Raja Atreya; Maryam Ghalibafian; Peter R. Galle; Markus F. Neurath 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 195 KB

Background: B-cells are considered to play a pathogenic role in human ulcerative colitis (UC) by producing autoantibodies that cause epithelial cell damage. Here we report on a patient with intractable UC who suffered from a severe exacerbation of UC after salvage therapy with rituximab, a B-cell-de

Transdermal Nicotine for Active Ulcerati
Transdermal Nicotine for Active Ulcerative Colitis
✍ Pullan, Rupert D.; Rhodes, John; Ganesh, Subramanian; Mani, Venk; Morris, John S 📂 Article 📅 1994 🏛 Massachusetts Medical Society 🌐 English ⚖ 832 KB